As part of our ongoing series focussing on new registrations in Australia, we have added a product review of the use of Safinamide for motor and non-motor symptoms of Parkinson’s disease
This review discusses epidemiology, pharmacological properties, effects on symptoms including mood, quality of life, pain and depression and prescribing considerations.
It also provides commentary and recommendations from Dr Kishore Kumar, staff specialist at Concord Hospital and a visiting scientist at the Garvan Institute.
Please login below to download this issue (PDF)